Lesional psoriatic T cells contain the capacity to induce a T cell activation molecule CDw60 on normal keratinocytes

American Journal of Pathology

Volumn 150, Issue 2, 1997, Pages 675-683

  Skov, Lone ^a   Chan, Lawrence S ^b   Fox, David A ^c   Larsen, Jørgen K ^e   Voorhees, John J ^d   Cooper, Kevin D ^f   Baadsgaard, Ole ^a  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

^b NORTHWESTERN UNIVERSITY   (United States)

^c UNIVERSITY OF MICHIGAN   (United States)

^d UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

^e FINSEN LABORATORY   (Denmark)

^f UNIVERSITY HOSPITALS OF CLEVELAND   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 13; INTERLEUKIN 2; INTERLEUKIN 4; INTERLEUKIN 6; MONOCLONAL ANTIBODY; SIALIDASE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL CULTURE; CELL CYCLE; GENE CONTROL; GENE EXPRESSION; HUMAN; KERATINOCYTE; MOUSE; PRIORITY JOURNAL; PSORIASIS; RECEPTOR UPREGULATION; STATISTICAL ANALYSIS; T LYMPHOCYTE ACTIVATION;

ANTIBODIES; ANTIGENS, CD; ANTIGENS, DIFFERENTIATION, T-LYMPHOCYTE; CELL CYCLE; CELLS, CULTURED; CLONE CELLS; CULTURE MEDIA, SERUM-FREE; HUMANS; INTERLEUKIN-13; INTERLEUKIN-4; KERATINOCYTES; LYMPHOCYTE ACTIVATION; PSORIASIS; REFERENCE VALUES; SKIN; T-LYMPHOCYTES;

EID: 0031028487     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Valdimarsson H, Baker BS, Jonsdottir I, Fry L: Psoriasis: a disease of abnormal keratinocyte proliferation induced by T lymphocytes. Immunol Today 1986, 7:256-259
2. + (CDw60) T cells are compartmentalized into psoriatic skin and release lymphokines that induce a keratinocyte phenotype expressed in psoriatic lesions. J Invest Dermatol 1990, 95:275-282
3. Strange P, Cooper KD, Hansen ER, Fisher G, Larsen JK, Fox DA, Krag C, Voorhees JJ, Baadsgaard O: T-lymphocyte clones initiated from lesional psoriatic skin release growth factors that induce keratinocyte proliferation. J Invest Dermatol 1993, 101:695-700
4. Bata Csorgo Z, Hammerberg C, Voorhees JJ, Cooper KD: Kinetics and regulation of human keratinocyte stem cell growth in short-term primary ex vivo culture: cooperative growth factors from psoriatic lesional T lymphocytes stimulate proliferation among psoriatic uninvolved, but not normal, stem keratinocytes. J Clin Invest 1995, 95:317-327
5. Prinz JC, Gross B, Vollmer S, Trommler P, Strobel I, Meurer M, Plewig G: T cell clones from psoriasis skin lesions can promote keratinocyte proliferation in vitro via secreted products. Eur J Immunol 1994, 24:593-598
6. Higgs JB, Zeldes W, Kozarsky K, Schteingart M, Kan L, Bohlke P, Krieger K, Davis W, Fox DA: A novel pathway of human T lymphocyte activation: identification by a monoclonal antibody generated against a rheumatoid synovial T cell line. J Immunol 1988, 140:3758-3765
7. Fox DA, Chan LS, Kan L, Baadsgaard O, Cooper KD: Expression and function of the UM4D4 antigen in human thymus, J Immunol 1989, 143:2166-2175
8. Hansen ER, Vejlsgaard GL, Cooper KD, Heidenheim M, Larsen JK, Ho VC, Ross CW, Fox DA, Thomsen K, Baadsgaard O: Leukemic T cells from patients with cutaneous T-cell lymphoma demonstrate enhanced activation through CDw60, CD2, and CD28 relative to activation through the T-cell antigen receptor complex. J Invest Dermatol 1993, 100:667-673
9. Kniep B, Peter-Katalinlc J, Flegel W, Northoff H, Rieber EP: CDw60 antibodies bind to acetylated forms of ganglioside GD3. Biochem Biophys Res Commun 1992, 187:1343-1349
10. Bremer EG, Hakomori S, Bowen Pope DF, Raines E, Ross R: Ganglioside-mediated modulation of cell growth, growth factor binding, and receptor phosphorylation. J Biol Chem 1984, 259:6818-6825
11. Paller AS, Arnsmeier SL, Alvarez-Franco M, Bremer EG: Ganglioside GM3 inhibits the proliferation of cultured keratinocytes. J Invest Dermatol 1993, 100:841-845
12. Hannun YA, Bell RM: Functions of sphingolipids and sphingolipid breakdown products in cellular regulation. Science 1989, 243:500-507
13. Markwell MA, Svennerholm L, Paulson JC: Specific gangliosides function as host cell receptors for Sendai virus. Proc Natl Acad Sci USA 1981, 78:5406-5410
14. Paller AS, Arnsmeier SL, Robinson JK, Bremer EG: Alteration in keratinocyte ganglioside content in basal cell carcinomas. J Invest Dermatol 1992, 98:226-232
15. Heidenheim M, Hansen ER, Baadsgaard O: CDw60, which identifies the acetylated form of GD3 gangliosides, is strongly expressed in human basal cell carcinoma. Br J Dermatol 1995, 133:392-397
16. Strange P, Skov L, Baadsgaard O: Interferon-γ-treated keratinocytes activate T cells in the presence of superantigens: involvement of major histocompatibility complex class II molecules. J Invest Dermatol 1994, 102:150-154
17. Schlaak JF, Buslau M, Jochum W, Hermann E, Girndt M, Gallati H, Meyer zum Buschenfelde K, Fleischer B: T cells involved in psoriasis vulgaris belong to the Th1 subset. J Invest Dermatol 1994, 102:145-149
18. Zurawski G, de Vries JE: Interleukin 13, an interleukin 4-like cytokine that acts on monocytes and B cells, but not on T cells. Immunol Today 1994, 15:19-26
19. Hilton DJ, Zhang JG, Metcalf D, Alexander WS, Nicola NA, Willson TA: Cloning and characterization of a binding subunit of the interleukin 13 receptor that is also a component of the interleukin 4 receptor. Proc Natl Acad Sci USA 1996, 93:497-501
20. de Waal Malefyt R, Figdor CG, Huijbens R, Mohan Peterson S, Bennett B, Culpepper J, Dang W, Zurawski G, de Vries JE: Effects of IL-13 on phenotype, cytokine production, and cytotoxic function of human monocytes: comparison with IL-4 and modulation by IFN-γ or IL-10. J Immunol 1993, 151:6370-6381
21. Uyemura K, Yamamura M, Fivenson DF, Modlin RL, Nickoloff BJ: The cytokine network in lesional and lesion-free psoriatic skin is characterized by a T-helper type 1 cell mediated response. J Invest Dermatol 1993, 101:701-705
22. Barna M, Snijdewint FG, van der Heijden FL, Bos JD, Kapsenberg ML: Characterization of lesional psoriatic skin T lymphocyte clones. Acta Derm Venereol Suppl Stockh 1994, 186:9-11
23. Grewe M, Walther S, Gyufko K, Czech W, Schöpf E, Krutmann J: Analysis of the cytokine pattern expressed in situ in inhalant allergen patch test reactions of atopic dermatitis patients. J Invest Dermatol 1995, 105:407-410
24. Kay AB, Ying S, Varney V, Gaga M, Durham SR, Moqbel R, Wardlaw AJ, Hamid Q: Messenger RNA expression of the cytokine gene cluster, interleukin 3 (IL-3), IL-4, IL-5, and granulocyte/macrophage colony-stimulating factor, in allergen-induced late-phase cutaneous reactions in atopic subjects. J Exp Med 1991, 173:775-778
25. Gottlieb AB, Lifshitz B, Fu SM, Staiano-Coico L, Wang CY, Carter DM: Expression of HLA-DR molecules by keratinocytes and presence of Langerhans cells in the dermal infiltrate of active psoriatic plaques. J Exp Med 1986, 164:1013-1028
26. Czernielewski JM, Bagot M: Class II MHC antigen expression by human keratinocytes results from lymphoepidermal interactions and γ-interferon production. Clin Exp Immunol 1986, 66:295-302
27. Barker JN, Goodlad JR, Ross EL, Yu CC, Groves RW, MacDonald DM: Increased epidermal cell proliferation in normal human skin in vivo following local administration of interferon-γ. Am J Pathol 1993, 142:1091-1097
28. Nickoloff BJ, Basham TY, Merigan TC, Morhenn VB: Antiproliferative effects of recombinant α- and γ-interferons on cultured human keratinocytes. Lab Invest 1984, 51:697-701
29. Baadsgaard O, Gupta AK, Taylor RS, Ellis CN, Voorhees JJ, Cooper KD: Psoriatic epidermal cells demonstrate increased numbers and function of non-Langerhans antigen-presenting cells. J Invest Dermatol 1989, 92:190-195